Literature DB >> 21602671

Treatment of acute coronary syndrome: Part 1: Non-ST-segment acute coronary syndrome.

Jeffrey C Trost1, Richard A Lange.   

Abstract

OBJECTIVE: Acute coronary syndrome is a common cause of morbidity and mortality, both in the United States and worldwide. The goal of this review is to familiarize clinicians with recent information regarding the diagnosis and treatment of acute coronary syndrome. DATA SOURCES: PubMed search and review of the relevant medical literature.
SUMMARY: Acute coronary syndrome encompasses three clinical diagnoses: unstable angina, non-ST-segment elevation myocardial infarction), and ST-segment elevation myocardial infarction. The definition, pathophysiology, clinical presentation, diagnosis, and treatment of unstable angina/non-ST-segment elevation myocardial infarction are reviewed here. Diagnosing unstable angina/non-ST-segment elevation myocardial infarction is a significant challenge in critically ill patients not initially suspected of having acute coronary syndrome (i.e., noncardiac intensive care unit patients), and diagnostic and treatment strategies for these patients have not been clearly established.
CONCLUSIONS: Patients with acute coronary syndrome benefit from intensive medical therapy, including antianginal, antiplatelet, antithrombotic, and statin agents. Depending on their risk for future cardiovascular events as well as their risk of bleeding complications, patients may benefit from either an early invasive treatment strategy, in which routine coronary revascularization is performed, or a conservative strategy, in which revascularization is reserved for patients with recurrent or provocable cardiac ischemia.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21602671     DOI: 10.1097/CCM.0b013e31821e855f

Source DB:  PubMed          Journal:  Crit Care Med        ISSN: 0090-3493            Impact factor:   7.598


  6 in total

Review 1.  Advanced drug delivery systems for antithrombotic agents.

Authors:  Colin F Greineder; Melissa D Howard; Ronald Carnemolla; Douglas B Cines; Vladimir R Muzykantov
Journal:  Blood       Date:  2013-06-24       Impact factor: 22.113

2.  In search of serenity: religious struggle among patients hospitalized for suspected acute coronary syndrome.

Authors:  Gina Magyar-Russell; Iain Tucker Brown; Inna R Edara; Michael T Smith; Joseph E Marine; Roy C Ziegelstein
Journal:  J Relig Health       Date:  2014-04

3.  Modulation of pre-capillary arteriolar pressure with drag-reducing polymers: a novel method for enhancing microvascular perfusion.

Authors:  John J Pacella; Marina V Kameneva; Judith Brands; Herbert H Lipowsky; Hans Vink; Linda L Lavery; Flordeliza S Villanueva
Journal:  Microcirculation       Date:  2012-10       Impact factor: 2.628

4.  Angiotensin converting enzyme DD genotype is associated with acute coronary syndrome severity and sudden cardiac death in Taiwan: a case-control emergency room study.

Authors:  Ying-Hsin Chen; Jui-Ming Liu; Ren-Jun Hsu; Sheng-Chuan Hu; Horng-Jyh Harn; Shee-Ping Chen; Jing-Ren Jeng; Chieh-Lin Wu; Jar-Yi Ho; Cheng-Ping Yu
Journal:  BMC Cardiovasc Disord       Date:  2012-02-15       Impact factor: 2.298

5.  The Improvement of Cardiac and Endothelial Functions of Xue-Fu-Zhu-Yu Decoction for Patients with Acute Coronary Syndrome: A Meta-Analysis of Randomized Controlled Trials.

Authors:  Shiqi Chen; Xiaoxiao Wu; Tong Li; Weiting Cheng; Xiaowan Han; Yang Li; Baofu Wang; Yu Teng; Mingjing Zhao; Yahong Wang
Journal:  Evid Based Complement Alternat Med       Date:  2022-02-10       Impact factor: 2.629

6.  A case-control study between gene polymorphisms of polyunsaturated fatty acid metabolic rate-limiting enzymes and acute coronary syndrome in Chinese Han population.

Authors:  Zikai Song; Hongyan Cao; Ling Qin; Yanfang Jiang
Journal:  Biomed Res Int       Date:  2013-02-28       Impact factor: 3.411

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.